The COVID-19 vaccine development landscape.Nat Rev Drug Discov. 2020 05; 19(5):305-306.NR
Links
MeSH
AgedBetacoronavirusCOVID-19COVID-19 VaccinesChildClinical Trials, Phase I as TopicCoronavirus InfectionsDrug DevelopmentDrug IndustryFemaleGenetic VectorsHumansInternationalityPandemicsPneumonia, ViralPregnancySARS-CoV-2Time FactorsVaccines, AttenuatedVaccines, InactivatedVaccines, SubunitVaccines, SyntheticViral Vaccines
Pub Type(s)
News
Language
eng
PubMed ID
32273591
Citation
Thanh Le, Tung, et al. "The COVID-19 Vaccine Development Landscape." Nature Reviews. Drug Discovery, vol. 19, no. 5, 2020, pp. 305-306.
Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305-306.
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews. Drug Discovery, 19(5), 305-306. https://doi.org/10.1038/d41573-020-00073-5
Thanh Le T, et al. The COVID-19 Vaccine Development Landscape. Nat Rev Drug Discov. 2020;19(5):305-306. PubMed PMID: 32273591.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The COVID-19 vaccine development landscape.
AU - Thanh Le,Tung,
AU - Andreadakis,Zacharias,
AU - Kumar,Arun,
AU - Gómez Román,Raúl,
AU - Tollefsen,Stig,
AU - Saville,Melanie,
AU - Mayhew,Stephen,
PY - 2020/4/11/pubmed
PY - 2020/5/7/medline
PY - 2020/4/11/entrez
SP - 305
EP - 306
JF - Nature reviews. Drug discovery
JO - Nat Rev Drug Discov
VL - 19
IS - 5
SN - 1474-1784
UR - https://www.unboundmedicine.com/medline/citation/32273591/The_COVID_19_vaccine_development_landscape_
DB - PRIME
DP - Unbound Medicine
ER -